The Function and Therapeutic Potential of Epstein-Barr Virus-Encoded MicroRNAs in Cancer
2019; Cell Press; Volume: 17; Linguagem: Inglês
10.1016/j.omtn.2019.07.002
ISSN2162-2531
AutoresMan Wang, Bianli Gu, Xinzhe Chen, Yefu Wang, Peifeng Li, Kun Wang,
Tópico(s)Circular RNAs in diseases
ResumoEpstein-Barr virus (EBV) is a ubiquitous human γ-herpesvirus that infects over 90% of the global population. EBV is considered a contributory factor in a variety of malignancies including nasopharyngeal carcinoma, gastric carcinoma, Burkitt lymphoma, and Hodgkin's lymphoma. Notably, EBV was the first virus found to encode microRNAs (miRNAs). Increasing evidence indicates that EBV-encoded miRNAs contribute to the carcinogenesis and development of EBV-associated malignancies. EBV miRNAs have been shown to inhibit the expression of genes involved in cell proliferation, apoptosis, invasion, and immune signaling pathways. Therefore, EBV miRNAs perform a significant function in the complex host-virus interaction and EBV-driven carcinogenesis. However, the integrated mechanisms underlying the roles of EBV miRNAs in carcinogenesis remain to be further explored. In this review, we describe recent advances regarding the involvement of EBV miRNAs in the pathogenesis of EBV-associated malignancies and discuss their potential utility as cancer biomarkers. An in-depth investigation into the pro-carcinogenic role of EBV miRNAs will expand our knowledge of the biological processes associated with virus-driven tumors and contribute to the development of novel therapeutic strategies for the treatment of EBV-associated malignancies. Epstein-Barr virus (EBV) is a ubiquitous human γ-herpesvirus that infects over 90% of the global population. EBV is considered a contributory factor in a variety of malignancies including nasopharyngeal carcinoma, gastric carcinoma, Burkitt lymphoma, and Hodgkin's lymphoma. Notably, EBV was the first virus found to encode microRNAs (miRNAs). Increasing evidence indicates that EBV-encoded miRNAs contribute to the carcinogenesis and development of EBV-associated malignancies. EBV miRNAs have been shown to inhibit the expression of genes involved in cell proliferation, apoptosis, invasion, and immune signaling pathways. Therefore, EBV miRNAs perform a significant function in the complex host-virus interaction and EBV-driven carcinogenesis. However, the integrated mechanisms underlying the roles of EBV miRNAs in carcinogenesis remain to be further explored. In this review, we describe recent advances regarding the involvement of EBV miRNAs in the pathogenesis of EBV-associated malignancies and discuss their potential utility as cancer biomarkers. An in-depth investigation into the pro-carcinogenic role of EBV miRNAs will expand our knowledge of the biological processes associated with virus-driven tumors and contribute to the development of novel therapeutic strategies for the treatment of EBV-associated malignancies. Epstein-Barr virus (EBV), also called human herpesvirus 4 (HHV-4), is a ubiquitous member of the human herpesvirus family and infects over 90% of the global population.1Cohen J.I. Fauci A.S. Varmus H. Nabel G.J. Epstein-Barr virus: an important vaccine target for cancer prevention.Sci. Transl. Med. 2011; 3: 107fs7Crossref PubMed Scopus (162) Google Scholar EBV was the first human tumor virus, and its infection is an etiologic factor in various epithelial and lymphoid malignancies, such as nasopharyngeal carcinoma (NPC), gastric carcinoma (GC), Burkitt lymphoma (BL), and Hodgkin's lymphoma (HL).2Jha H.C. Pei Y. Robertson E.S. Epstein-Barr Virus: Diseases Linked to Infection and Transformation.Front. Microbiol. 2016; 7: 1602Crossref PubMed Scopus (25) Google Scholar, 3Javier R.T. Butel J.S. The history of tumor virology.Cancer Res. 2008; 68: 7693-7706Crossref PubMed Scopus (111) Google Scholar, 4Ko Y.H. EBV and human cancer.Exp. Mol. Med. 2015; 47: e130Crossref PubMed Scopus (19) Google Scholar Despite its tight association with a variety of malignancies, primary EBV infection commonly causes no or slight symptoms in most lifelong carriers.5Young L.S. Rickinson A.B. Epstein-Barr virus: 40 years on.Nat. Rev. Cancer. 2004; 4: 757-768Crossref PubMed Scopus (1386) Google Scholar, 6Vockerodt M. Yap L.F. Shannon-Lowe C. Curley H. Wei W. Vrzalikova K. Murray P.G. The Epstein-Barr virus and the pathogenesis of lymphoma.J. Pathol. 2015; 235: 312-322Crossref PubMed Scopus (97) Google Scholar In infected cells, EBV can establish two alternative modes of infections known as latent or lytic.7Li H. Hu J. Luo X. Bode A.M. Dong Z. Cao Y. Therapies based on targeting Epstein-Barr virus lytic replication for EBV-associated malignancies.Cancer Sci. 2018; 109: 2101-2108Crossref PubMed Scopus (2) Google Scholar Upon primary infection, EBV transiently undergoes a short lytic program in the epithelial cells of the oropharynx and salivary glands, and subsequently establishes lifelong latent infection in memory B cells.8Murata T. Tsurumi T. Switching of EBV cycles between latent and lytic states.Rev. Med. Virol. 2014; 24: 142-153Crossref PubMed Scopus (0) Google Scholar, 9Cohen J.I. Epstein-Barr virus infection.N. Engl. J. Med. 2000; 343: 481-492Crossref PubMed Scopus (1097) Google Scholar During latency, EBV expresses a limited number of viral latent genes, which is advantageous for its long-term persistence in infected cells.10Kenney S.C. Mertz J.E. Regulation of the latent-lytic switch in Epstein-Barr virus.Semin. Cancer Biol. 2014; 26: 60-68Crossref PubMed Scopus (111) Google Scholar Infected B cells would switch from latency into the lytic stage upon stimulation.11Li H. Liu S. Hu J. Luo X. Li N. M Bode A. Cao Y. Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis.Int. J. Biol. Sci. 2016; 12: 1309-1318Crossref PubMed Scopus (19) Google Scholar During the lytic stage, a repertoire of over 80 viral genes is expressed, accompanied by viral DNA replication, resulting in the production of progeny viruses.12Ressing M.E. van Gent M. Gram A.M. Hooykaas M.J. Piersma S.J. Wiertz E.J. Immune Evasion by Epstein-Barr Virus.Curr. Top. Microbiol. Immunol. 2015; 391: 355-381PubMed Google Scholar Both EBV latent and lytic infections have been shown to contribute to the carcinogenesis and development of EBV-associated tumors.13Elgui de Oliveira D. Müller-Coan B.G. Pagano J.S. Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers.Trends Microbiol. 2016; 24: 649-664Abstract Full Text Full Text PDF PubMed Scopus (0) Google Scholar, 14Shah K.M. Young L.S. Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma.Clin. Microbiol. Infect. 2009; 15: 982-988Abstract Full Text Full Text PDF PubMed Scopus (0) Google Scholar, 15Hong G.K. Gulley M.L. Feng W.H. Delecluse H.J. Holley-Guthrie E. Kenney S.C. Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model.J. Virol. 2005; 79: 13993-14003Crossref PubMed Scopus (145) Google Scholar, 16Fiorini S. Ooka T. Secretion of Epstein-Barr virus-encoded BARF1 oncoprotein from latently infected B cells.Virol. J. 2008; 5: 70Crossref PubMed Scopus (23) Google Scholar, 17Fang C.Y. Lee C.H. Wu C.C. Chang Y.T. Yu S.L. Chou S.P. Huang P.T. Chen C.L. Hou J.W. Chang Y. et al.Recurrent chemical reactivations of EBV promotes genome instability and enhances tumor progression of nasopharyngeal carcinoma cells.Int. J. Cancer. 2009; 124: 2016-2025Crossref PubMed Scopus (62) Google Scholar MicroRNAs (miRNAs) are endogenous small non-coding RNAs (ncRNAs) that exert a powerful effect on gene regulation through inducing mRNA degradation or translational inhibition.18Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function.Cell. 2004; 116: 281-297Abstract Full Text Full Text PDF PubMed Scopus (23785) Google Scholar, 19Grundhoff A. Sullivan C.S. Virus-encoded microRNAs.Virology. 2011; 411: 325-343Crossref PubMed Scopus (243) Google Scholar Accumulating evidence demonstrates that miRNAs are engaged in diverse physiological and pathological processes, including development, metabolism, and cancer.20Wahid F. Shehzad A. Khan T. Kim Y.Y. MicroRNAs: synthesis, mechanism, function, and recent clinical trials.Biochim. Biophys. Acta. 2010; 1803: 1231-1243Crossref PubMed Scopus (360) Google Scholar, 21Wei F. Yang S. Wang S. MicroRNAs: a critical regulator under mechanical force.Histol. Histopathol. 2018; 33: 335-342PubMed Google Scholar, 22Jansson M.D. Lund A.H. MicroRNA and cancer.Mol. Oncol. 2012; 6: 590-610Crossref PubMed Scopus (650) Google Scholar More importantly, miRNAs function as crucial players in the onset and progression of cancer.23Balatti V. Pekarky Y. Croce C.M. Role of microRNA in chronic lymphocytic leukemia onset and progression.J. Hematol. Oncol. 2015; 8: 12Crossref PubMed Scopus (0) Google Scholar, 24O'Bryan S. Dong S. Mathis J.M. Alahari S.K. The roles of oncogenic miRNAs and their therapeutic importance in breast cancer.Eur. J. Cancer. 2017; 72: 1-11Abstract Full Text Full Text PDF PubMed Google Scholar, 25Chen E. Xu X. Liu R. Liu T. Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression.BioMed Res. Int. 2018; 2018: 6784607PubMed Google Scholar Intriguingly, EBV was the first virus in which viral miRNAs were detected.26Pfeffer S. Zavolan M. Grässer F.A. Chien M. Russo J.J. Ju J. John B. Enright A.J. Marks D. Sander C. Tuschl T. Identification of virus-encoded microRNAs.Science. 2004; 304: 734-736Crossref PubMed Scopus (1135) Google Scholar EBV can encode 44 mature miRNAs from 25 miRNA precursors.27Barth S. Meister G. Grässer F.A. EBV-encoded miRNAs.Biochim. Biophys. Acta. 2011; 1809: 631-640Crossref PubMed Scopus (76) Google Scholar A growing body of evidence underlines the regulatory roles of EBV-encoded miRNAs in the carcinogenesis and progression of EBV-associated malignancies.28Navari M. Etebari M. Ibrahimi M. Leoncini L. Piccaluga P.P. Pathobiologic Roles of Epstein-Barr Virus-Encoded MicroRNAs in Human Lymphomas.Int. J. Mol. Sci. 2018; 19: 1168Crossref Scopus (5) Google Scholar, 29Vojtechova Z. Tachezy R. The Role of miRNAs in Virus-Mediated Oncogenesis.Int. J. Mol. Sci. 2018; 19: 1217Crossref Scopus (7) Google Scholar EBV miRNAs are capable of interfering with a wide range of biological processes, such as cell proliferation, apoptosis, transformation, and invasion. Moreover, EBV miRNAs can directly target immune-related genes and thus enable infected cells to evade immune destruction. In this review, we summarize the current understanding of the functional roles of EBV-encoded miRNAs in the pathogenesis of human malignancies. Increasing understanding of the involvement of EBV miRNAs in cancer progression may accelerate our efforts to comprehensively reveal the molecular mechanisms underlying EBV-induced carcinogenesis and propel the development of novel therapeutic measures for EBV-associated malignancies. In infected cells, EBV adopts a biphasic life cycle consisting of latent and lytic phases.30Murata T. Regulation of Epstein-Barr virus reactivation from latency.Microbiol. Immunol. 2014; 58: 307-317Crossref PubMed Scopus (0) Google Scholar During the lytic cycle, the full repertoire of viral genes is expressed, and progeny viruses are produced.31Sinclair A.J. Epigenetic control of Epstein-Barr virus transcription—relevance to viral life cycle?.Front. Genet. 2013; 4: 161Crossref PubMed Google Scholar The lytic cycle allows the dissemination of virions among host cells. During the course of latency, EBV expresses a limited quantity of viral genes essential for the maintenance of its genome.32Andrei G. Trompet E. Snoeck R. Novel Therapeutics for Epstein–Barr Virus.Molecules. 2019; 24: e997Crossref PubMed Scopus (0) Google Scholar Because only a few viral proteins that can be targeted by the host immune system are produced, the latent infection of EBV facilitates its survive and pathogenesis.33Dugan J.P. Coleman C.B. Haverkos B. Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders.Front. Oncol. 2019; 9: 127Crossref PubMed Scopus (0) Google Scholar According to the expression of latent genes, EBV latency can be categorized into four different types.5Young L.S. Rickinson A.B. Epstein-Barr virus: 40 years on.Nat. Rev. Cancer. 2004; 4: 757-768Crossref PubMed Scopus (1386) Google Scholar Latency 0 is found only in healthy carriers, in which no viral proteins are generated or low levels of EBV nuclear antigen 1 (EBNA1) and latent membrane protein 2A (LMP2A) can be detected in B lymphocytes.34Dong M. Chen J.N. Huang J.T. Gong L.P. Shao C.K. The roles of EBV-encoded microRNAs in EBV-associated tumors.Crit. Rev. Oncol. Hematol. 2019; 135: 30-38Crossref PubMed Scopus (0) Google Scholar BL generally presents a latency I type, in which only EBNA1 is expressed.35Rowe M. Rowe D.T. Gregory C.D. Young L.S. Farrell P.J. Rupani H. Rickinson A.B. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.EMBO J. 1987; 6: 2743-2751Crossref PubMed Google Scholar In latency II, three LMPs (LMP1, LMP2A, and LMP2B) are expressed in addition to EBNA1.36Brooks L. Yao Q.Y. Rickinson A.B. Young L.S. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.J. Virol. 1992; 66: 2689-2697PubMed Google Scholar Moreover, latency II is tightly associated with NPC, HL, and natural killer (NK)/T cell lymphoma. Latency III is characterized by expression of all nuclear proteins (EBNA1, 2, 3A, 3B, 3C, and -LP), the three LMPs, and viral ncRNAs.37Thorley-Lawson D.A. Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas.N. Engl. J. Med. 2004; 350: 1328-1337Crossref PubMed Scopus (656) Google Scholar Latency III is the least restrictive latency type and is commonly found in immunodeficiency-associated lymphoma, such as post-transplant lymphoproliferative disorder (PTLD) and AIDS-related lymphoma. miRNAs are a highly conserved group of small ncRNAs, which are 21–25 nt in length.38He L. Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation.Nat. Rev. Genet. 2004; 5: 522-531Crossref PubMed Scopus (4579) Google Scholar miRNAs can be derived from exons of non-coding genes, introns of coding and non-coding genes, and the intragenic regions.39Shukla G.C. Singh J. Barik S. MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions.Mol. Cell. Pharmacol. 2011; 3: 83-92PubMed Google Scholar The canonical miRNA biogenesis pathway involves two processing steps that have been extensively defined in previous studies.40Hammond S.M. An overview of microRNAs.Adv. Drug Deliv. Rev. 2015; 87: 3-14Crossref PubMed Scopus (467) Google Scholar, 41Chong M.M. Zhang G. Cheloufi S. Neubert T.A. Hannon G.J. Littman D.R. Canonical and alternate functions of the microRNA biogenesis machinery.Genes Dev. 2010; 24: 1951-1960Crossref PubMed Scopus (141) Google Scholar, 42Daugaard I. Hansen T.B. Biogenesis and Function of Ago-Associated RNAs.Trends Genet. 2017; 33: 208-219Abstract Full Text Full Text PDF PubMed Scopus (54) Google Scholar In brief, the miRNA genes are transcribed to generate long primary miRNA (pri-miRNA) molecules by RNA polymerase II (Pol II) or Pol III.43Lee Y. Kim M. Han J. Yeom K.H. Lee S. Baek S.H. Kim V.N. MicroRNA genes are transcribed by RNA polymerase II.EMBO J. 2004; 23: 4051-4060Crossref PubMed Scopus (2696) Google Scholar, 44Borchert G.M. Lanier W. Davidson B.L. RNA polymerase III transcribes human microRNAs.Nat. Struct. Mol. Biol. 2006; 13: 1097-1101Crossref PubMed Scopus (904) Google Scholar The nascent pri-miRNAs are first processed into ∼70-nt precursor miRNAs (pre-miRNAs) by a microprocessor complex consisting of Drosha and DiGeorge syndrome critical region 8 (DGCR8) in the nucleus. Pre-miRNAs, characterized by hairpin structures, are then exported to the cytoplasm by exportin-5, where they are further processed by Dicer to yield mature miRNA duplexes (21–25 nt).45Shivdasani R.A. MicroRNAs: regulators of gene expression and cell differentiation.Blood. 2006; 108: 3646-3653Crossref PubMed Scopus (298) Google Scholar One strand of the duplex is preferentially incorporated into the RNA-induced silencing complex (RISC) containing Argonaute (Ago), and is guided to target mRNAs.46Berkhout B. Jeang K.T. RISCy business: MicroRNAs, pathogenesis, and viruses.J. Biol. Chem. 2007; 282: 26641-26645Crossref PubMed Scopus (0) Google Scholar miRNAs mainly recognize complementary sequences in the 3′ UTRs of their target mRNAs.47Brennecke J. Stark A. Russell R.B. Cohen S.M. Principles of microRNA-target recognition.PLoS Biol. 2005; 3: e85Crossref PubMed Scopus (1624) Google Scholar The interaction between miRNAs and mRNAs causes mRNA degradation or translation suppression, contributing to altered gene expression. miRNAs play a significant role in various biological processes including proliferation, apoptosis, and differentiation.48Li M. Marin-Muller C. Bharadwaj U. Chow K.H. Yao Q. Chen C. MicroRNAs: control and loss of control in human physiology and disease.World J. Surg. 2009; 33: 667-684Crossref PubMed Scopus (105) Google Scholar They are also implicated in the occurrence and progression of cancer.49Peng Y. Croce C.M. The role of MicroRNAs in human cancer.Signal Transduct. Target. Ther. 2016; 1: 15004Crossref PubMed Google Scholar, 50Hayes J. Peruzzi P.P. Lawler S. MicroRNAs in cancer: biomarkers, functions and therapy.Trends Mol. Med. 2014; 20: 460-469Abstract Full Text Full Text PDF PubMed Google Scholar So far, the function and mechanisms of miRNAs in cancer pathogenesis have been disclosed. Based on their abundance and target genes, miRNAs are mainly divided into two categories: oncogenic and tumor-suppressive miRNAs.51Adams B.D. Anastasiadou E. Esteller M. He L. Slack F.J. The Inescapable Influence of Noncoding RNAs in Cancer.Cancer Res. 2015; 75: 5206-5210Crossref PubMed Scopus (26) Google Scholar EBV is the first virus in which miRNAs are discovered.26Pfeffer S. Zavolan M. Grässer F.A. Chien M. Russo J.J. Ju J. John B. Enright A.J. Marks D. Sander C. Tuschl T. Identification of virus-encoded microRNAs.Science. 2004; 304: 734-736Crossref PubMed Scopus (1135) Google Scholar EBV encodes 44 miRNAs that are transcribed from two regions: BamHI-A region rightward transcript (BART) and BamHI fragment H rightward open reading frame 1 (BHRF1) clusters.52Klinke O. Feederle R. Delecluse H.J. Genetics of Epstein-Barr virus microRNAs.Semin. Cancer Biol. 2014; 26: 52-59Crossref PubMed Scopus (50) Google Scholar BART transcript encodes 22 miRNA precursors (miR-BART1-22) with 40 mature miRNAs, whereas BHRF1 transcript expresses three miRNA precursors (miR-BHRF1-1, -2, and -3) producing four mature miRNAs.27Barth S. Meister G. Grässer F.A. EBV-encoded miRNAs.Biochim. Biophys. Acta. 2011; 1809: 631-640Crossref PubMed Scopus (76) Google Scholar Intriguingly, EBV miRNAs are differentially expressed in an infection stage-dependent manner. The expression of BART miRNAs takes place in all types of latency and is more restricted to the latency types I and II.53Kang M.S. Kieff E. Epstein-Barr virus latent genes.Exp. Mol. Med. 2015; 47: e131Crossref PubMed Scopus (107) Google Scholar In contrast, BHRF1 miRNAs are abundantly expressed in type III latency and lytically infected cells, such as B lymphoma cells, but are nearly undetectable in cells under the latency types I and II.54Navari M. Fuligni F. Laginestra M.A. Etebari M. Ambrosio M.R. Sapienza M.R. Rossi M. De Falco G. Gibellini D. Tripodo C. et al.Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus.Front. Microbiol. 2014; 5: 728Crossref PubMed Scopus (0) Google Scholar, 55Sakamoto K. Sekizuka T. Uehara T. Hishima T. Mine S. Fukumoto H. Sato Y. Hasegawa H. Kuroda M. Katano H. Next-generation sequencing of miRNAs in clinical samples of Epstein-Barr virus-associated B-cell lymphomas.Cancer Med. 2017; 6: 605-618Crossref PubMed Scopus (7) Google Scholar, 56Amoroso R. Fitzsimmons L. Thomas W.A. Kelly G.L. Rowe M. Bell A.I. Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation.J. Virol. 2011; 85: 996-1010Crossref PubMed Scopus (0) Google Scholar The expression difference between BART and BHRF1 miRNAs is attributed to distinct promoters responsible for their transcription. Likewise, EBV miRNAs are differentially expressed in different types of cancer. Several studies were previously conducted to profile the expression of EBV-encoded miRNAs in cancer. miR-BART7, miR-BART9, miR-BART14*, miR-BART17-3p, and miR-BART22 were found to be the most abundant viral miRNAs in NPC samples.57Cosmopoulos K. Pegtel M. Hawkins J. Moffett H. Novina C. Middeldorp J. Thorley-Lawson D.A. Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma.J. Virol. 2009; 83: 2357-2367Crossref PubMed Scopus (0) Google Scholar Zhu et al.58Zhu J.Y. Pfuhl T. Motsch N. Barth S. Nicholls J. Grässer F. Meister G. Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas.J. Virol. 2009; 83: 3333-3341Crossref PubMed Scopus (0) Google Scholar revealed that miR-BART1, miR-BART4, miR-BART6, miR-BART7, and miR-BART11 were abundantly expressed in NPC. High levels of miR-BART3-3p, miR-BART4-5p, miR-BART5-5p, miR-BART7-3p, and miR-BART9-3p were detected in NPC samples.59Chen S.J. Chen G.H. Chen Y.H. Liu C.Y. Chang K.P. Chang Y.S. Chen H.C. Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing.PLoS ONE. 2010; 5: e12745Crossref PubMed Scopus (0) Google Scholar Microarray-based viral miRNA profile in NPC demonstrated that miR-BART1-3p, miR-BART3, miR-BART5, miR-BART7, and miR-BART8* showed high abundance.60Gourzones C. Jimenez A.S. Busson P. Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.Cancer. 2012; 118 (author reply 4634–4635): 4634Crossref PubMed Scopus (9) Google Scholar Moreover, EBV miRNAs accounted for approximately 19% of total miRNAs in one NPC sample. Another study also reported the expression profile of EBV miRNAs in NPC.61Wan X.X. Yi H. Qu J.Q. He Q.Y. Xiao Z.Q. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.Oncol. Rep. 2015; 34: 2585-2601Crossref PubMed Scopus (9) Google Scholar A total of nine BART miRNAs (miR-BART1-5p, 3, 4, 5, 6-3p, 7, 8, 10, and 18-3p) were identified to be upregulated. Notably, all of these studies verified a significant upregulation of miR-BART7 in EBV-positive NPC, suggesting that miR-BART7 might play an important role in the carcinogenesis and progression of NPC. EBV miRNAs were demonstrated to account for about 15% of total miRNAs in EBV-infected AGS GC cell lines.62Marquitz A.R. Mathur A. Chugh P.E. Dittmer D.P. Raab-Traub N. Expression profile of microRNAs in Epstein-Barr virus-infected AGS gastric carcinoma cells.J. Virol. 2014; 88: 1389-1393Crossref PubMed Scopus (0) Google Scholar The most abundant viral miRNAs in AGS cells were miR-BART6-3p, miR-BART7-5p, miR-BART8-5p, miR-BART10-3p, and miR-BART22. Expression of EBV miRNAs in EBV-associated GC (EBVaGC) samples and cell lines was further profiled by deep sequencing.63Shinozaki-Ushiku A. Kunita A. Isogai M. Hibiya T. Ushiku T. Takada K. Fukayama M. Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis.J. Virol. 2015; 89: 5581-5591Crossref PubMed Scopus (0) Google Scholar miR-BART1-3p, miR-BART5-5p, miR-BART7-3p, miR-BART9-3p, and miR-BART10-3p had high abundance. Tsai et al.64Tsai C.Y. Liu Y.Y. Liu K.H. Hsu J.T. Chen T.C. Chiu C.T. Yeh T.S. Comprehensive profiling of virus microRNAs of Epstein-Barr virus-associated gastric carcinoma: highlighting the interactions of ebv-Bart9 and host tumor cells.J. Gastroenterol. Hepatol. 2017; 32: 82-91Crossref PubMed Scopus (11) Google Scholar found that miR-BART2-5p, miR-BART4-5p, miR-BART6-3p, miR-BART9-3p, and miR-BART1s1-3p were the most abundant in EBVaGC samples and cell lines. Collectively, BART miRNAs account for a large proportion of total viral miRNAs in EBV-positive epithelial tumors, suggesting that BART miRNAs may be associated with the development of epithelial malignancies. In EBV-positive diffuse large B cell lymphoma (DLBCL) samples, all BART miRNAs were detected with the exception of miR-BART15 and miR-BART22.65Imig J. Motsch N. Zhu J.Y. Barth S. Okoniewski M. Reineke T. Tinguely M. Faggioni A. Trivedi P. Meister G. et al.microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma.Nucleic Acids Res. 2011; 39: 1880-1893Crossref PubMed Scopus (0) Google Scholar Remarkably, miR-BART7, miR-BART10, miR-BART11-5p, miR-BART16, and miR-BART22 were the most abundantly expressed miRNAs. The most highly expressed viral miRNAs in NK/T cell lymphoma included miR-BART1-5p, miR-BART5, miR-BART7, miR-BART11-5p, and miR-BART19-3p.66Motsch N. Alles J. Imig J. Zhu J. Barth S. Reineke T. Tinguely M. Cogliatti S. Dueck A. Meister G. et al.MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing.PLoS ONE. 2012; 7: e42193Crossref PubMed Scopus (0) Google Scholar In endemic BL, miR-BART6-3p, miR-BART7, miR-BART10, miR-BART11-3p, and miR-BART17-5p were the most abundant EBV miRNAs.67Oduor C.I. Movassagh M. Kaymaz Y. Chelimo K. Otieno J. Ong'echa J.M. Moormann A.M. Bailey J.A. Human and Epstein-Barr Virus miRNA Profiling as Predictive Biomarkers for Endemic Burkitt Lymphoma.Front. Microbiol. 2017; 8: 501Crossref PubMed Scopus (0) Google Scholar It seems that miR-BART7 and miR-BART11 act as vital participants in the pathogenesis of EBV-associated lymphoma. However, BHRF1 miRNAs were not found in all these types of lymphoma but could be detected in PTLD and AIDS-related DLBCL.68Xia T. O'Hara A. Araujo I. Barreto J. Carvalho E. Sapucaia J.B. Ramos J.C. Luz E. Pedroso C. Manrique M. et al.EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3.Cancer Res. 2008; 68: 1436-1442Crossref PubMed Scopus (0) Google Scholar, 69Fink S.E. Gandhi M.K. Nourse J.P. Keane C. Jones K. Crooks P. Jöhrens K. Korfel A. Schmidt H. Neumann S. et al.A comprehensive analysis of the cellular and EBV-specific microRNAome in primary CNS PTLD identifies different patterns among EBV-associated tumors.Am. J. Transplant. 2014; 14: 2577-2587Crossref PubMed Scopus (0) Google Scholar The deregulation of EBV miRNAs might contribute to viral infection and pathogenesis. It has been reported that the strain and type of EBV, and the background of infected cells may affect the expression level of viral miRNAs.70Tsai M.H. Lin X. Shumilov A. Bernhardt K. Feederle R. Poirey R. Kopp-Schneider A. Pereira B. Almeida R. Delecluse H.J. The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers.Oncotarget. 2017; 8: 10238-10254Crossref PubMed Scopus (28) Google Scholar, 71Correia S. Palser A. Elgueta Karstegl C. Middeldorp J.M. Ramayanti O. Cohen J.I. Hildesheim A. Fellner M.D. Wiels J. White R.E. et al.Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNA.J. Virol. 2017; 91 (e00375-e17)Crossref Scopus (19) Google Scholar The transcription factors in infected cells can also modulate EBV miRNA expression. For instance, the nuclear factor-κB (NF-κB) signaling was able to upregulate the expression of BART miRNAs in NPC.72Verhoeven R.J. Tong S. Zhang G. Zong J. Chen Y. Jin D.Y. Chen M.R. Pan J. Chen H. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.J. Virol. 2016; 90: 6475-6488Crossref PubMed Scopus (0) Google Scholar Nevertheless, further studies are required to disclose the regulatory mechanisms of EBV miRNA expression. Furthermore, the association between aberrantly expressed viral miRNAs and EBV-associated malignancies remains to be systemically explored. EBV is a well-recognized carcinogen that is directly implicated in the etiology of human epithelial and lymphoid malignancies.73Thompson M.P. Kurzrock R. Epstein-Barr virus and cancer.Clin. Cancer Res. 2004; 10: 803-821Crossref PubMed Scopus (497) Google Scholar, 74Khan G. Hashim M.J. Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010.Infect. Agent. Cancer. 2014; 9: 38Crossref PubMed Google Scholar It is believed that EBV miRNAs perform a crucial role in the pathobiology of EBV-associated malignancies.75Skalsky R.L. Cullen B.R. EBV Noncoding RNAs.Curr. Top. Microbiol. Immunol. 2015; 391: 181-217PubMed Google Scholar In terms of mechanism, EBV miRNAs are able to modulate various cellular pathways such as cell proliferation, apoptosis, invasion, metastasis, and immune signaling by targeting cellular or viral mRNAs. EBV miRNAs are able to regulate cell proliferation or apoptosis, contributing to the carcinogenesis of EBV-associated malignancies. The previous report indicated that BART miRNAs could potentiate the seeding and growth of EBVaGC in vivo.76Qiu J. Smith P. Leahy L. Thorley-Lawson D.A. The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo.PLoS Pathog. 2015; 11: e1004561Crossref PubMed Scopus (0) Google Scholar Deregulated BART miRNAs were implicated in NPC tumorigenesis by interfering with signaling pathways associated with proliferation, apoptosis, invasion, and metastasis.77Xie Y.J. Long Z.F. He X.S. Involvement of EBV-encoded BART-miRNAs and dysregulated cellular miRNAs in nasopharyngeal carcinoma genesis.Asian Pac. J. Cancer Prev. 2013; 14: 5637-5644Crossref PubMed Scopus (15) Google Scholar Upregulated BART miRNAs (e.g., miR-BART3 and miR-BART5) were predicted to target genes involved in the p53, transforming growth factor-β (TGF-β), and Wnt signaling pathways, thus modulating NPC apoptosis and transformation.6
Referência(s)